CIIE: Join CIIE to embrace opportunities in Chinese market
25.5.2021 13:37:06 CEST | news aktuell GmbH | Press release

(Shanghai, China): Are you still searching for the right gateway to enter the Chinese market? Are you looking to boost your sales activities and network with potential trade partners in China? Are you seeking more media exposure that costs little to nothing? The China International Import Expo (CIIE) may be just the perfect channel to help you achieve these goals.
What is CIIE? The CIIE is the world's largest import expo and one of the top 10 business shows in the world. It is evolving to be a must-attend event for multinationals in every November in Shanghai.
Why attend it? Firstly, its scale and breadth of industries. Last year, it covered 360,000 square meters, or about the size of 70 football fields. Secondly, high-quality participants and exhibits. 10,000 exhibitors attended the first three editions, including many Global Fortune 500 companies and industry leaders. More than 1,300 products and services have made their global or Chinese debuts over the past three expos. Thirdly, opportunities to meet purchasers, land new projects and enter the Chinese market. Some 1.3 million Chinese buyers attended the first three editions. Over the past three expos, deals were signed worth more than $200 billion. Following these deals, a total of 319 projects from the first two expos, backed by foreign investment worth $15 billion, have been initiated and successfully launched in China. Fourthly, free media exposure. At CIIE, participants can promote their brands and gain media exposure, with global media outlets attending each year to report on the latest trends, products and innovations being shown at the fair. In the first three editions, more than 10,000 journalists covered the expo.
Intelligent Industry and Information Technology Exhibition Area in focus. Among the different segments at CIIE, the Intelligent Industry Information Technology Exhibition Area is one of the most important stages for manufacturing firms to showcase their latest products and technology. To manufacturing firms still wondering if you should take part in the CIIE, come see for yourself the companies that have already signed up for the fourth CIIE. You can also network with them and seek potential cooperation in advance.
Click on the following links to check out who they are!
List of first batch of exhibitors for 4th CIIE:
https://www.ciie.org/zbh/en/news/exhibition/official/20210315/27245.html
List of second batch of exhibitors for 4th CIIE:
https://www.ciie.org/zbh/en/news/exhibition/official/20210407/27547.html
List of third batch of exhibitors for 4th CIIE:
https://www.ciie.org/zbh/en/news/exhibition/official/20210512/27943.html
How to attend it? Please visit
https://www.ciie.org/ciie/f/book/register?locale=en
to REGISTER.
Contacts
Contact: Nie Qingxin
Tel.: 0086-21-67008870/67008988
Images

About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Webasto Air Top Pro 25: a new, exceptionally quiet parking heater for campers22.10.2026 13:52:44 CEST | Press release
Why should the camping season end just because summer is over? The colder months offer unique experiences—from skiing and snowshoeing to simply enjoying the winter landscape. To ensure your motorhome or campervan remains a comfortable retreat even in low temperatures, the right heating solution is crucial.
Polarise Launches Sovereign AI Cloud at NVIDIA GTC Berlin, Delivering Enterprise AI From Data Center to Application22.10.2026 10:00:00 CEST | Press release
With Polarise Rise and Polarise Drive, the German AI provider extends its own European AI Factories into a full-stack sovereign cloud
Democracy News Alliance: Fiscal strength doesn't guarantee public goods delivery, US study finds21.10.2026 09:55:20 CEST | Press release
New York/DNA - A newly released study of US state government performance found strong partisan and regional patterns within three pillars of governance: democratic accountability, state capacity and public goods provision. Yet, the US states’ outcomes differ in important ways from international comparisons, as the three governance dimensions show limited correlation, the researchers found.
agineo expands partnership with ServiceNow, launches AI Control Tower as a Service20.10.2026 13:06:01 CEST | Press release
New managed service provides transparency into the AI landscape and helps companies centrally manage AI, monitor risks and regulatory requirements, and highlight business benefits.
Grünenthal advances proprietary Nociceptin Receptor (NOP) Agonist into Phase II trial in acute pain20.10.2026 10:17:49 CEST | Press release
Potential first-in-class, selective nociceptin receptor (NOP) agonist that aims to provide safe, effective treatment for moderate to severe acute pain. Following successful Phase I results earlier this year demonstrating an excellent safety profile, the program has now progressed to Phase II. The randomized, double-blind, double-dummy, placebo- and active controlled, 2-part Phase II trial will evaluate the safety, tolerability and efficacy of this novel NOP agonist in patients post bunionectomy surgery. Grünenthal anticipates reporting results in early 2028.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom

